A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
Linnaeus Therapeutics, Inc.
Linnaeus Therapeutics, Inc.
Incyte Corporation
DEKA Biosciences
Taproot Health
Celldex Therapeutics
Myeloid Therapeutics
GlaxoSmithKline
AVAX Technologies
Bristol-Myers Squibb
Pfizer
FeRx